Continue taking that daily low-dose aspirin for its cardiovascular benefits, but don’t expect it to protect against age-related declines in memory and thinking. That’s the word from researchers who observed nearly 6,400 women ages 65 and older who participated in the National Institutes of Health Women’s Health Study. The women were randomly divided into two groups, with one group taking 100 milligrams of aspirin on alternate days and the other taking a placebo. They were all assessed by phone every two years during the nearly 10-year study. Results, published online in the British Medical Journal, show that overall performance from the first test to the final assessment was similar in both the aspirin and placebo groups: Neither group showed a difference in the risk of cognitive decline or memory loss.